Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review

BACKGROUND: Methotrexate (MTX) is the cornerstone disease-modifying anti-rheumatic drug in juvenile idiopathic arthritis (JIA). In JIA, it is important to start effective treatment early to avoid long-term sequelae, such as joint damage. To accomplish this goal, it is crucial to know beforehand who...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatr Rheumatol Online J
Hlavní autoři: van Dijkhuizen, EH Pieter, Wulffraat, Nico M
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4269851/
https://ncbi.nlm.nih.gov/pubmed/25525416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-12-51
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky